Ortigosa, Luciena C.M., et al. “Infliximab Does Not Lead to Reduction in the Interferon-Gamma and Lymphoproliferative Responses of Patients With Moderate to Severe Psoriasis”. Acta Dermato-Venereologica, vol. 94, no. 1, July 2013, pp. 26-31, doi:10.2340/00015555-1650.